Propofol Withdrawal Dyskinesia in a Parkinson's Disease Patient with Levodopa-Induced Dyskinesia

被引：0
|
作者：
Nakajima, Asuka [1 ,2 ]
Iwamuro, Hirokazu [3 ]
Tokugawa, Joji [4 ]
Odo, Masahiko [5 ]
Shimo, Yasushi [1 ,2 ]
机构：
[1] Juntendo Univ Nerima Hosp, Dept Neurol, Tokyo, Japan
[2] Juntendo Univ, Sch Med, Dept Res & Therapeut Movement Disorders, Tokyo, Japan
[3] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo, Japan
[4] Juntendo Univ Nerima Hosp, Dept Neurosurg, Tokyo, Japan
[5] Juntendo Univ Nerima Hosp, Dept Anesthesia & Pain Med, Tokyo, Japan
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2023年 / 50卷 / 02期
基金：
日本学术振兴会;
关键词：
Dyskinesia; Propofol; Parkinson's disease; Deep brain stimulation; Cortico-basal ganglia circuits; DOPAMINE TURNOVER;
D O I：
10.1017/cjn.2022.4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [21] Risk factors for levodopa-induced dyskinesia in Parkinson's disease patients
    Djuric, Gordana
    Markovic, Vladana
    Pekmezovic, Tatjana
    Tomic, Aleksandra
    Kresojevic, Nikola
    Kostic, Vladimir
    Svetel, Marina
    VOJNOSANITETSKI PREGLED, 2017, 74 (10) : 921 - 926
  • [22] Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment
    Theresa A. Zesiewicz
    Kelly L. Sullivan
    Robert A. Hauser
    Current Neurology and Neuroscience Reports, 2007, 7 : 302 - 310
  • [23] White matter alterations in Parkinson's disease with levodopa-induced dyskinesia
    Ogawa, Takashi
    Hatano, Taku
    Kamagata, Koji
    Andica, Christina
    Takeshige-Amano, Haruka
    Uchida, Wataru
    Saito, Yuya
    Shimo, Yasushi
    Oyama, Genko
    Umemura, Atsushi
    Iwamuro, Hirokazu
    Ito, Masanobu
    Hori, Masaaki
    Aoki, Shigeki
    Hattori, Nobutaka
    PARKINSONISM & RELATED DISORDERS, 2021, 90 : 8 - 14
  • [24] Pridopidine for the treatment of Levodopa-induced Dyskinesia in patients with Parkinson's disease
    Geva, M.
    McGarry, A.
    Cohen, Y.
    Johnston, T.
    de Somer, M.
    Kieburtz, K.
    Hayden, M.
    Brotchie, J.
    Olanow, C.
    MOVEMENT DISORDERS, 2020, 35 : S396 - S396
  • [25] CARDINAL SYMPTOMS OF PARKINSON'S DISEASE COHABIT WITH LEVODOPA-INDUCED DYSKINESIA
    Goubault, E.
    Nguyen, H. P.
    Bogard, S.
    Faucher, G.
    Duval, C.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E12 - E12
  • [26] Levetiracetam (Keppra) in the treatment of levodopa-induced dyskinesia in Parkinson's disease
    Zesiewicz, TA
    Sullivan, KL
    Maldonado, JL
    Tatum, WO
    Hauser, RA
    NEUROLOGY, 2004, 62 (07) : A510 - A510
  • [27] Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?
    Chaudhuri, K. Ray
    Jenner, Peter
    Antonini, Angelo
    MOVEMENT DISORDERS, 2019, 34 (06) : 816 - 819
  • [28] The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease
    Brotchie, JM
    ANNALS OF NEUROLOGY, 2000, 47 (04) : S105 - S114
  • [29] EEG biofeedback training for Parkinson's disease with levodopa-induced dyskinesia
    Erickson-Davis, C.
    Anderson, J.
    Richter, S.
    Wielinski, C.
    Parashos, S.
    MOVEMENT DISORDERS, 2009, 24 : S59 - S59
  • [30] Quantitative electroencephalographic profile of Parkinson's disease with levodopa-induced dyskinesia
    Erickson-Davis, C. R.
    Anderson, J. S.
    Wielinski, C. L.
    Parashos, S. A.
    Krohn, S.
    MOVEMENT DISORDERS, 2008, 23 (01) : S300 - S300
12345